# A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations

> **NCT02249936** · PHASE1 · COMPLETED · sponsor: **Ardelyx** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD1722
- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT02249936
- **Lead sponsor:** Ardelyx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2014-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02249936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02249936, "A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02249936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*